CEO: | Paul Carmelo Pagano |
Chief Finance Officer: | David Mark Anderson |
Independent Non-Executive Director: | James Renwick McCullough |
Non-Executive Chairman: | Gordon Roy Davis |
Senior Independent Non-Executive Director: | Andrew Norman Boteler |
Non-Executive Dir: | Sara Barrington |
Address: | 850 New Burton Road, Suite 201, Dover, Delaware, USA, 19904 |
Website: | https://www.lunglifeai.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
Domestic Listings: | LSE:LLA |
ISIN: | USU5500L1045 |
Currency | UK Pounds |
Share Price | 26.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 123.00 |
52 Week Low | 19.00 |
Volume | 18,615 |
Shares Issued | 25.49m |
Market Cap | £6.63m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:06 | 1,202 @ 25.13p |
08:48 | 12,413 @ 25.00p |
08:17 | 5,000 @ 25.13p |
You are here: research